List of Excipients in API AMBRISENTAN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing AMBRISENTAN
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Gilead Sciences Inc | LETAIRIS | ambrisentan | 61958-0801 | ALUMINUM OXIDE | |
Gilead Sciences Inc | LETAIRIS | ambrisentan | 61958-0801 | CELLULOSE, MICROCRYSTALLINE | |
Gilead Sciences Inc | LETAIRIS | ambrisentan | 61958-0801 | CROSCARMELLOSE SODIUM | |
Gilead Sciences Inc | LETAIRIS | ambrisentan | 61958-0801 | FD&C RED NO. 40 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing AMBRISENTAN
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 | ANHYDROUS LACTOSE |
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 | CELLULOSE, MICROCRYSTALLINE |
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 | CROSCARMELLOSE SODIUM |
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 | FD&C BLUE NO. 2 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for AMBRISENTAN
Excipient focus: ALUMINUM OXIDE
AMBRISENTAN drug variants containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
Apotex Corp | ambrisentan | 60505-4552 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
Par Pharmaceutical Inc | ambrisentan | 49884-353 |
Aurobindo Pharma Limited | ambrisentan | 59651-494 |
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
AMBRISENTAN drug variants containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
Par Pharmaceutical Inc | ambrisentan | 49884-353 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
AMBRISENTAN drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
AMBRISENTAN drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
AMBRISENTAN drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ambrisentan | 0591-2405 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
Par Pharmaceutical Inc | ambrisentan | 49884-353 |
Aurobindo Pharma Limited | ambrisentan | 59651-494 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
AMBRISENTAN drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ambrisentan | 0591-2405 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
AMBRISENTAN drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | ambrisentan | 60505-4552 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
AMBRISENTAN drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
Par Pharmaceutical Inc | ambrisentan | 49884-353 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
>Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
AMBRISENTAN drug variants containing LECITHIN, SOYBEAN
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ambrisentan | 0591-2405 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
Par Pharmaceutical Inc | ambrisentan | 49884-353 |
Aurobindo Pharma Limited | ambrisentan | 59651-494 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing LECITHIN, SOYBEAN
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
Apotex Corp | ambrisentan | 60505-4552 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
AMBRISENTAN drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
AMBRISENTAN drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Zydus Pharmaceuticals USA Inc | ambrisentan | 70710-1179 |
Zydus Lifesciences Limited | ambrisentan | 70771-1363 |
Quallent Pharmaceuticals Health LLC | ambrisentan | 82009-141 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
AMBRISENTAN drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Par Pharmaceutical Inc | ambrisentan | 49884-353 |
Cipla USA Inc | ambrisentan | 69097-386 |
Zydus Pharmaceuticals USA Inc | ambrisentan | 70710-1179 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
AMBRISENTAN drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | ambrisentan | 49884-353 |
Cipla USA Inc | ambrisentan | 69097-386 |
Exelan Pharmaceuticals Inc | ambrisentan | 76282-684 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
AMBRISENTAN drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
AMBRISENTAN drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | ambrisentan | 70710-1179 |
Zydus Lifesciences Limited | ambrisentan | 70771-1363 |
Quallent Pharmaceuticals Health LLC | ambrisentan | 82009-141 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
AMBRISENTAN drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | ambrisentan | 47335-236 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
AMBRISENTAN drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
AMBRISENTAN drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | ambrisentan | 0378-4270 |
Actavis Pharma Inc | ambrisentan | 0591-2405 |
AvKARE | ambrisentan | 42291-018 |
Sigmapharm Laboratories LLC | ambrisentan | 42794-051 |
>Company | >Ingredient | >NDC |
AMBRISENTAN drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.